B BNTX

BioNTech SE

BIOTECHNOLOGY · HEALTHCARE

BioNTech SE, headquartered in Mainz, Germany, is a prominent biotechnology company focused on the development and commercialization of innovative immunotherapies targeting cancer and infectious diseases. Widely recognized for its pivotal collaboration with Pfizer that resulted in a pioneering COVID-...

$87.53

-0.73% ($0.64)

Volume 709,983

52W High $124.00

52W Low $79.52

Market Cap $21.99B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Nov 3, 2026 Beat

Actual: $1.76 vs. Consensus: $0.76

Price Chart

EPS History: Consensus vs Actual

Last 8 quarters

Price Movement Around Earnings

Q3 2026 Nov 2, 2026

1-Day: -0.70%

Q2 2026 Aug 4, 2026

1-Day: +0.91%

Q2 2026 Aug 3, 2026

1-Day: -0.98%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'25	$1.52B	+22.0%	90.2%	-3.1%	-$28.7M
Q2'25	$260.8M	+102.6%	70.7%	-192.1%	-$386.6M
Q1'25	$182.8M	-2.6%	54.2%	-292.2%	-$415.8M
Q4'24	$1.19B	-19.5%	79.5%	12.5%	$259.5M
Q3'24	$1.24B	+39.0%	85.6%	0.8%	$198.1M
Q2'24	$128.7M	-23.3%	53.5%	-750.7%	-$807.8M
Q1'24	$187.6M	-85.3%	68.5%	-270.4%	-$315.1M
Q4'23	$1.48B	-65.4%	87.9%	35.6%	$457.9M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Nov 3, 2026	$0.76	$0.72	$1.76	--	Beat
Q3 2026	Nov 2, 2026	$0.54	$0.51	--	--	--
Q2 2026	Aug 4, 2026	-$2.58	-$2.58	-$3.03	-17.44%	Missed
Q2 2026	Aug 3, 2026	-$2.44	-$2.44	--	--	--
Q1 2026	May 11, 2026	-$2.03	-$2.03	-$1.95	+3.94%	Beat
Q1 2026	May 5, 2026	-$1.92	-$1.92	-$1.95	-1.56%	Missed
Q1 2026	May 4, 2026	-$2.29	-$2.29	--	--	--
Q4 2025	Mar 10, 2026	-$0.25	-$0.09	-$0.33	-33.50%	Missed
Q4 2025	Mar 9, 2026	-$0.57	-$0.57	--	--	--
Q3 2025	Nov 3, 2025	$0.10	$0.12	-$0.12	--	Missed
Q2 2025	Aug 4, 2025	-$1.41	-$1.41	-$1.60	-13.48%	Missed
Q1 2025	May 16, 2025	-$2.35	-$2.35	-$1.82	+22.42%	Beat